IL33 and lung carcinoma: In addition, it is reported that IL-33 could promote the differentiation and maturation of DCs, which augmented the antitumor effect of CD8+ T cells and NK cells and inhibited the proliferation of lung cancer cells through affecting MyD88 pathway (84).